Physician profile
Matthew Hand
NPI 1992797799
$1,499.92
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $561 · 2022: $676 · 2023: $182 · 2024: $80.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $262.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $429.96 | 2022 | |
| Janssen Pharmaceuticals, INC | $266.35 | 2021-2022 | |
| Abbott Laboratories | $145.01 | 2021-2023 | Mitraclip |
| Novo Nordisk INC | $117.79 | 2021-2023 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $90.77 | 2021-2024 | Camzyos, Eliquis |
| Amgen INC. | $63.77 | 2021 | |
| Baxter Healthcare | $58.17 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $49.35 | 2021-2024 | Lifevest |
| Astellas Pharma US INC | $39.99 | 2021 | |
| Sanofi-Aventis U.S. LLC | $36.63 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $29.45 | 2021 | |
| Kerecis Limited | $25.20 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Kestra Medical Technology Services, INC. | $21.59 | 2023 | Assure Wcd |
| Angiodynamics, INC. | $18.72 | 2022 | |
| Bolton Medical INC | $17.12 | 2024 | Treo Abdominal Stent-Graft System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $15.93 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $15.88 | 2021 | |
| Cvrx, INC. | $15.32 | 2024 | Barostim Neo System |
| Amarin Pharma, INC. | $15.26 | 2021 | |
| Impulse Dynamics (USA) INC. | $14.77 | 2023 | Optimizer |
| Esperion Therapeutics, INC. | $12.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Hand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.